"Psychedelics: Effectors of Neuroinflammatory Programming"
Presenter: Austin Perlmutter, MD
Original Date: July 21, 2024
Brain-related diseases and disorders are among the most debilitating and deadly conditions on Earth. Yet by and large, conventional pharmaceutical management targeting individual neurotransmitters or proteins (e.g., serotonin in depression, amyloid beta in Alzheimer’s dementia) have fallen short of expectations. This has led to a growing interest in identifying additional disease-related pathways and interventions to help ameliorate physical, emotional and economic costs. In this conversation, neuroinflammation and psychedelics have each emerged as areas of intense academic research and potential sources of solutions. Neuroinflammation is now believed to underlie or significantly contribute to mental health, cognitive, neurodevelopmental and behavior disorders and diseases. Psychedelics represent promising compounds for ameliorating a host of brain-related conditions. In this presentation, we’ll explore the known overlap between the two domains while looking ahead towards the promise this may hold for the future of brain health.
Bio: Dr. Austin Perlmutter is a board-certified internal medicine physician, New York Times bestselling author, published researcher and international educator. His mission is to help people improve their health by targeting the biological basis of “stuckness” in our brains and bodies. His writing, presentations, podcasts, and online educational programs explore how environmental factors influence our cognitive and mental state and have reached millions. Dr. Perlmutter has been featured on PBS, Rolling Stone, MedPage today, Newsweek, Medical News Today, NPR and a wide range of other media outlets. He is a co-producer of the Alzheimer’s, the Science of Prevention series, and host of the Better Brain Blueprint series. Dr. Perlmutter currently serves as the managing director at Big Bold Health, a food-as-medicine company focused on helping people rejuvenate health through better immune function, where he is running a first-of-its kind study exploring the effects of plant nutrients on human aging through epigenetics.
NUNM is accredited by the North American Naturopathic Continuing Education Council (NANCEAC). This activity qualifies for 1.0 General, 0.5 Pharmacology CEUs.